A panel of health experts advising the government on the pandemic on Thursday help open deliberations on the coronavirus vaccine for children aged 5-11 years old. Following authorization of the modified dose of the Pfizer vaccine for children by US health regulatory bodies, Israel is widely expected to approve its use as well. Prof. Nadav Davidovitch, Director of the School of Public Health at Ben Gurion University, and chair of the health policy program at the Taub Center, told KAN reporter Naomi Segal that holding the public hearing was important for building trust in the decision-making process.